NCT02123459View on ClinicalTrials.gov

A Study of Cephalexin Suspension in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Cephalexin

Administered orally

Trial Locations (1)

14610

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City

All Listed Sponsors
collaborator

Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V.

OTHER

lead

Eli Lilly and Company

INDUSTRY

NCT02123459 - A Study of Cephalexin Suspension in Healthy Participants | Biotech Hunter | Biotech Hunter